MedTrace Logo

TIKeasy TAblet satisfaCtion (TikTac)

NCT04091152 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 60

Last updated 2019-10-01

No results posted yet for this study

Summary

In the last ten years, gerontechnology is becoming an increasing topic in geriatric medicine. Nevertheless, there are still few studies assessing the usability of technologies in old patients, especially when they are hospitalized. Moreover, it has been shown that new technologies could be a source of ageism, thence the importance of involving the old people in the development of these technologies.

Tik easy is a subsidiary of La Poste Company. Tik easy as designed a new tablet PC for old people. Research tends to show that the use of tablet PC can promote health and well-aging, and delay cognitive decline. In this study, we want to give a free access to "Ardoiz", the tablet PC designed by Tik easy, for old patients hospitalized in a geriatric acute care unit. The "Ardoiz" tablet PC allows to:

* Maintain the family and social bond (send and receive messages, share photos and videos, call remotely between the patient and his family)
* Discovering the Internet at his own pace (browse the Internet with daily updated contents such as news, content on cooking, music, etc.).
* Prevent cognitive aging (stimulate cognitive abilities with the DYNSEO games).
* Facilitate online administrative procedures.

Conditions

  • Old Age; Debility
  • Satisfaction

Interventions

OTHER

usability assessment

Usability of "ardoiz" will be assesse using a validated usability questionnary

Sponsors & Collaborators

  • University Hospital, Angers

    lead OTHER_GOV

Principal Investigators

  • Cedric Annweiler, MD, PhD · Angers University Hospital

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2019-09-19
Primary Completion
2020-09-16
Completion
2020-09-25

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04091152 on ClinicalTrials.gov